Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Buybacks
  • Dividends
  • Earnings
  • General
  • Health Care
  • Large Cap
  • Mid Cap
  • News

Recession Investing: 5 High Yield Dividend Stocks For A Downturn

By Robert Kuczmarski
August 3, 2:23 PM
As the healthcare industry absorbed enormous amounts of profits during the Covid-19 pandemic, many healthcare companies will be increasing shareholder distributions to entice investors to buy their stock.

ABBV

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target

Sarepta’s Duchenne Gene Therapy Update Gets Bullish Stance From Analysts

By Vandana Singh
August 3, 2:20 PM
Sarepta Therapeutics Inc (NASDAQ:SRPT) reported above-consensus 2Q FY22 product sales of $211 million and provided more details on the path forward…

SRPT

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Novo Nordisk Shares Fall After Q2 Earnings Despite Raised Annual Outlook

By Vandana Singh
August 3, 2:01 PM
Novo Nordisk A/S (NYSE:NVO) reported Q2 sales of DKK41.27 billion, +25% Y/Y (+15% on a constant currency basis). Operating profit…

NVO

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • News
  • Price Target
  • Small Cap

This Stock Offers ‘Attractive Opportunity For Small Cap Growth Exposure’ In Healthcare Services

By Vandana Singh
August 3, 1:49 PM
Stephens initiated coverage on ModivCare Inc (NASDAQ:MODV) with an Overweight rating and a $145 price target.  ModivCare represents an attractive opportunity for…

ADUS

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Health Care
  • News
  • Penny Stocks
  • Small Cap

Amarin Still Suspends FY22 Guidance On Generic Challenges

By Vandana Singh
August 3, 12:51 PM
Amarin Corporation plc (NASDAQ:AMRN) continues suspending 2022 revenue guidance citing the ongoing global impact of COVID-19, the uncertainty resulting from the…

AMRN

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

AmerisourceBergen Boosts FY22 Profit Outlook As Q3 Beat Expectations

By Vandana Singh
August 3, 12:00 PM
AmerisourceBergen Corp’s (NYSE:ABC) Q3 FY22 adjusted EPS reached $2.62, up 21.3% Y/Y, beating the consensus of $2.57. Revenue of $60.1…

ABC

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Regeneron’s Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity

By Vandana Singh
August 3, 11:57 AM
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned $9.77 per share for Q2 FY22, down 62% Y/Y, beating the $9.54 estimate.  Sales decreased…

REGN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Merrimack Pharma-Ipsen’s Cancer Drug Fails In Overall Survival Measure

By Vandana Singh
August 3, 11:49 AM
Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) partner announced that Ipsen SA (OTC:IPSEY) reported a primary analysis of the results of the…

IPSEF

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Horizon Therapeutics’ Shares Tumble On Q2 Miss, Trimmed FY22 Outlook

By Vandana Singh
August 3, 11:14 AM
Horizon Therapeutics plc’s (NASDAQ:HZNP) reported Q2 sales of $876.4 million, +5% Y/Y, missing the consensus of $936.10 million. The adjusted…

HZNP

Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Movers
  • News
  • Trading Ideas

Owens & Minor Shares Slip On FY22 Outlook Cut

By Akanksha Bakshi
August 3, 11:00 AM
Owens & Minor Inc (NYSE:OMI) reported second-quarter revenue of $2.50 billion, an increase of 0.44% year-over-year, missing the consensus of…

OMI

Posts pagination

Previous 1 … 452 453 454 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service